JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A5057 MGCD-265 analog

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A5449 PIK-93

Summary: PI3Kγ/PI4KIIIβ/PI3Kα inhibitor

insoluble in H2O; ≥19.5 mg/mL
A5455 AEE788 (NVP-AEE788)

Summary: EGFR/HER-2/VEGFR inhibitor

≥22.05 mg/mL
A5511 Ofloxacin

Target: Topoisomerases|DNA gyrase

Summary: Fluoroquinolones,antibiotics

insoluble in H2O; insoluble in EtOH; ≥12.03 mg/mL
A5719 AT7519

Target: Cyclin-Dependent Kinases

Summary: Multi-CDK inhibitor
A1947 MEK162 (ARRY-162, ARRY-438162)

Target: MEK

Summary: MEK1/2 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
A8331 Bleomycin Sulfate

13 Citation

Summary: DNA synthesis inhibitor

≥125 mg/mL
A8460 Levodopa

Summary: Dopamine precursor.

insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL
A8413 Diperodon HCl

Summary: A prodrug compound activated by serum enzyme catalysis.

insoluble in H2O; ≥16.8 mg/mL
B1583 UNC1999

3 Citation

Target: EZH2|EZH1

Summary: EZH2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥28.5 mg/mL